3013 SCIENCE PARK, SAN DIEGO, CA
Financial Results, Press Release
Investor Presentation
Announces Third Quarter 2025 Financial Results and Provides Business Update
Unregistered Sales of Equity Securities
Announces Second Quarter 2025 Financial Results and Provides Business Update
Material disclosure
Announces Completion of Enrollment in Registrational Phase 3 PROSERA Study for the Treatment of PAH
Q3
Q2
Q1
FY 2024
FY 2023
Effectiveness Notice
S-3ASR
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
RW
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Automatic Shelf Registration Statement
Correspondence